Atypical psychotropics not more dangerous than conventional antipsychotics, study finds

Share this article:
Atypical antipsychotic medications are no more dangerous than other conventional antipsychotics, antidepressants and benzodiazepines when it comes to treating nursing home residents, according to a new study. Although psychotropic drugs are commonly used to treat nursing home patients with dementia, these treatments are not approved by the Food and Drug Administration. The FDA has advised that both atypical and common antipsychotics are associated with an increased risk of death, and that certain atypical antipsychotics, such as risperidone, olanzapine and aripiprazole, are associated with an increased risk of stroke, according to researchers from Brigham and Women's Hospital in Boston.
http://www.brighamandwomens.org/
Share this article:
close

Next Article in Products

More in Products

LeadingAge's CAST releases medication management tools

LeadingAge's Center for Aging Services Technologies release new tools last week to help long-term care providers identify the best medication management product.

Butler Mobility updates paint colors for platform lifts

Butler Mobility updates paint colors for platform lifts

Butler Mobility has widened the spectrum of paint color choices for its Incline Platform Lifts line.

NeuroMetrix releases pain management system

NeuroMetrix releases pain management system

NeuroMetrix Inc. has created the SENSUS™ Pain Management System, a wearable neurostimulation technology developed for chronic neuropathic pain, including painful diabetic neuropathy.